Both in Pharmaceuticals
Biohaven vs Zymeworks
Over the past year BHVN returned −8.9% and ZYME returned +48.1%; their daily moves had a correlation of 0.19.
BHVN −8.9% ZYME +48.1%Growth of $1, one year, split-adjusted
| Metric | BHVN | ZYME |
|---|---|---|
| Price | $16.49 | $28.71 |
| Market cap | $2.49B | $2.06B |
| Today | +6.25% | −0.66% |
| 1 month | +23.5% | +8.4% |
| 6 months | +71.9% | +4.2% |
| Year to date | +46.1% | +9.0% |
| 1 year | −4.1% | +48.8% |
| Revenue growth (YoY) | — | −90.6% |
| Gross margin | — | 100.0% |
| Net margin | — | −980.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 55.6× |
| Net cash | $8.4M | $270.7M |
| Dividend yield | — | — |
| Volatility (60d) | 90.4% | 46.7% |
| Short % of float | 14.9% | 13.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).